The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer

by Zhenbo Tu, Johannes Schmoellerl, Odette Mariani, Yurong Zheng, Yi Hu, Anne Vincent-Salomon, Antoine E. Karnoub
Published 2021-05-01

Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors

by Matthias Christgen, Gábor Cserni, Giuseppe Floris, Caterina Marchio, Lounes Djerroudi, Hans Kreipe, Patrick W. B. Derksen, Anne Vincent-Salomon
Published 2021-07-01

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells

by Olivier Zajac, Renaud Leclere, André Nicolas, Didier Meseure, Caterina Marchiò, Anne Vincent-Salomon, Sergio Roman-Roman, Marie Schoumacher, Thierry Dubois
Published 2020-01-01

Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer

by Virginie Mieulet, Camille Garnier, Yann Kieffer, Thomas Guilbert, Fariba Nemati, Elisabetta Marangoni, Gilles Renault, Foucauld Chamming’s, Anne Vincent-Salomon, Fatima Mechta-Grigoriou
Published 2021-02-01

Distinct expression profiles and functions of Kindlins in breast cancer

by Paula Azorin, Florian Bonin, Ahmad Moukachar, Aurélie Ponceau, Sophie Vacher, Ivan Bièche, Elisabetta Marangoni, Laetitia Fuhrmann, Anne Vincent-Salomon, Rosette Lidereau, Keltouma Driouch
Published 2018-11-01

Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression

by Haifeng Xu, Haifeng Xu, Tonje Lien, Helga Bergholtz, Thomas Fleischer, Lounes Djerroudi, Anne Vincent-Salomon, Therese Sørlie, Tero Aittokallio, Tero Aittokallio, Tero Aittokallio
Published 2021-06-01

HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports

by Alexandra Arfi, Delphine Hequet, Guillaume Bataillon, Carine Tran-Perennou, Fereshteh Farkhondeh, Xavier Sastre-Garau, Virginie Fourchotte, Roman Rouzier, Enora Laas, Nicolas Pouget, Anne Vincent-Salomon, Emmanuelle Jeannot
Published 2019-04-01

HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients.

by Marianne Tuefferd, Jérôme Couturier, Françoise Penault-Llorca, Anne Vincent-Salomon, Philippe Broët, Jean-Paul Guastalla, Djelila Allouache, Martin Combe, Béatrice Weber, Eric Pujade-Lauraine, Sophie Camilleri-Broët
Published 2007-11-01

A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer

by Claire Bonneau, Antoine Eliès, Yann Kieffer, Brigitte Bourachot, Sylvain Ladoire, Floriane Pelon, Delphine Hequet, Jean-Marc Guinebretière, Christophe Blanchet, Anne Vincent-Salomon, Roman Rouzier, Fatima Mechta-Grigoriou
Published 2020-07-01

miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers

by Anne-Marie Givel, Yann Kieffer, Alix Scholer-Dahirel, Philemon Sirven, Melissa Cardon, Floriane Pelon, Ilaria Magagna, Géraldine Gentric, Ana Costa, Claire Bonneau, Virginie Mieulet, Anne Vincent-Salomon, Fatima Mechta-Grigoriou
Published 2018-03-01

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma

by Fabien Reyal, Marc A. Bollet, Martial Caly, David Gentien, Sabrina Carpentier, Hélène Peyro-Saint-Paul, Jean-Yves Pierga, Paul Cottu, Véronique Dieras, Brigitte Sigal-Zafrani, Anne Vincent-Salomon, Xavier Sastre-Garau
Published 2012-01-01

Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma.

by Fabien Reyal, Marc A Bollet, Martial Caly, David Gentien, Sabrina Carpentier, Hélène Peyro-Saint-Paul, Jean-Yves Pierga, Paul Cottu, Véronique Dieras, Brigitte Sigal-Zafrani, Anne Vincent-Salomon, Xavier Sastre-Garau
Published 2012-01-01

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma.

by Fabien Reyal, Marc A. Bollet, Martial Caly, David Gentien, Sabrina Carpentier, Hélène Peyro-Saint-Paul, Jean-Yves Pierga, Paul Cottu, Véronique Dieras, Brigitte Sigal-Zafrani, Anne Vincent-Salomon, Xavier Sastre-Garau
Published 2012-01-01

RalB directly triggers invasion downstream Ras by mobilizing the Wave complex

by Giulia Zago, Irina Veith, Manish Kumar Singh, Laetitia Fuhrmann, Simon De Beco, Amanda Remorino, Saori Takaoka, Marjorie Palmeri, Frédérique Berger, Nathalie Brandon, Ahmed El Marjou, Anne Vincent-Salomon, Jacques Camonis, Mathieu Coppey, Maria Carla Parrini
Published 2018-10-01

Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients

by Lauren Darrigues, Jean-Yves Pierga, Alice Bernard-Tessier, Ivan Bièche, Amanda Bartolini Silveira, Marc Michel, Delphine Loirat, Paul Cottu, Luc Cabel, Coraline Dubot, Romain Geiss, Francesco Ricci, Anne Vincent-Salomon, Charlotte Proudhon, François-Clément Bidard
Published 2021-03-01

Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.

by Anne Vincent-Salomon, Vanessa Benhamo, Eléonore Gravier, Guillem Rigaill, Nadège Gruel, Stéphane Robin, Yann de Rycke, Odette Mariani, Gaëlle Pierron, David Gentien, Fabien Reyal, Paul Cottu, Alain Fourquet, Roman Rouzier, Xavier Sastre-Garau, Olivier Delattre
Published 2013-01-01

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast

by Ivan Bièche, Florence Coussy, Rania El-Botty, Sophie Vacher, Sophie Château-Joubert, Ahmed Dahmani, Elodie Montaudon, Cécile Reyes, David Gentien, Fabien Reyal, Francesco Ricci, André Nicolas, Caterina Marchio, Anne Vincent-Salomon, Marick Laé, Elisabetta Marangoni
Published 2021-09-01

PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy

by Beatriz Grandal, Manon Mangiardi-Veltin, Enora Laas, Marick Laé, Didier Meseure, Guillaume Bataillon, Elsy El-Alam, Lauren Darrigues, Elise Dumas, Eric Daoud, Anne Vincent-Salomon, Laure-Sophie Talagrand, Jean-Yves Pierga, Fabien Reyal, Anne-Sophie Hamy
Published 2021-02-01

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.

by Hélène Bonsang-Kitzis, Delphine Mouttet-Boizat, Eugénie Guillot, Jean-Guillaume Feron, Virginie Fourchotte, Séverine Alran, Jean-Yves Pierga, Paul Cottu, Florence Lerebours, Denise Stevens, Anne Vincent-Salomon, Brigitte Sigal-Zafrani, François Campana, Roman Rouzier, Fabien Reyal
Published 2017-01-01

The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.

by Fabien Reyal, Roman Rouzier, Berenice Depont-Hazelzet, Marc A Bollet, Jean-Yves Pierga, Severine Alran, Remy J Salmon, Virginie Fourchotte, Anne Vincent-Salomon, Xavier Sastre-Garau, Martine Antoine, Serge Uzan, Brigitte Sigal-Zafrani, Yann De Rycke
Published 2011-01-01